Cephanone, a new semisynthetic cephalosporin available for parenteral administration, is similar to cephalothin and cephaloridine in its antibacterial spectrum. Wick and Preston (12) found higher serum concentrations of cephanone than of cephalothin or cephaloridine after subcutaneous injections in mice, and Meyers et al. (8) reported serum levels in volunteers that were significantly higher than those obtained with equal doses of cephalothin or cephaloridine given intravenously or intramuscularly. These pharmacological characteristics of cephanone are similar to those of cefazolin (9), another heterocyclic cephalosporin with a closely related chemical structure.
Cephanone, a new semisynthetic cephalosporin available for parenteral administration, is similar to cephalothin and cephaloridine in its antibacterial spectrum. Wick and Preston (12) found higher serum concentrations of cephanone than of cephalothin or cephaloridine after subcutaneous injections in mice, and Meyers et al. (8) reported serum levels in volunteers that were significantly higher than those obtained with equal doses of cephalothin or cephaloridine given intravenously or intramuscularly. These pharmacological characteristics of cephanone are similar to those of cefazolin (9) , another heterocyclic cephalosporin with a closely related chemical structure.
In the present study, cephanone serum levels and urinary excretion were determined in healthy volunteers after intravenous infusions and intramuscular injections to elucidate the pharmacokinetic properties of this new antibiotic.
MATERIALS AND METHODS
Four male volunteers received an intravenous infusion of cephanone for 3 h through a pediatric scalp vein needle by using a constant-infusion pump (Harvard Apparatus Co.). A loading dose of 3.5 mg/kg (approximately 250 mg) was diluted in 50 ml of saline and injected over the 1st h, followed by a sustaining dose of 1.5 mg/kg (approximately 100 mg) in 50 ml of saline hourly for the next 2 h to obtain a steady state during the 3rd h. Blood samples for the measurement of antibiotic concentrations were drawn at 1 h, four times during the next 2 h (end of the infusion), and at least seven times from 3 to 10 h. The urinary excretion was determined by assays of timed urine collections over 24 h.
Single intramuscular injections of 7 mg (approximately 500 mg) of cephanone per kg were given to five volunteers. Twelve blood samples were drawn during the next 8 h, at short intervals during the 1st 2 h to define the peak concentration, and then at 0.5-and 1-h intervals during the declining phase. Antibiotic concentrations in the urine were determined by assays of specimens collected from 0 to 4, 4 to 8, and 8 to 24 h. A sample from a pool of all the urine collected throughout the 24-h period was also assayed, and the total excretion of cephanone determined in this manner agreed closely with the results obtained by adding the amounts recovered in the different fractions.
The 5-ml blood samples were allowed to clot and were centrifuged, and serum and urine were frozen at -20 C until time for bioassay. Cephanone concentrations were measured by an agar-well diffusion assay method (2) by using Bacillus subtilis ATCC 6633 as the indicator organism.
The serum half-life was calculated during the elimination phase (from 4 to 10 h for the intravenous infusion study and from 3 to 8 h after intramuscular injection), when the cephanone serum levels declined exponentially, with the formula (4) T /2 = (ln 2)1(K.) where ln 2 is the natural logarithm of 2 and K, is the slope of the regression line determined by the method of least squares. The apparent volume of distribution was calculated during the 3rd h of the intravenous infusion study with the formula VD.
where VDU, is defined as the volume of distribution in liters under steady-state conditions; ko is the steadystate infusion rate in milligrams per h, and C0o is the steady-state serum concentration in sg/ml. The total or serum clearance was calculated from the steadystate data with the formula Pcl = (ko/C0o x (1.73 m2/BSA) where BSA is the body surface area. The renal clearance was calculated in two volunteers during the intravenous infusion study by using urine collected at from 3 to 7 h, and the serum level at 5 h was obtained by interpolating the serum concentration from the regression line, and in five volunteers renal clearance was calculated during the intramuscular injection study by using the urine collected at from 4 to 8 h as was the corresponding serum level at 6 h, with the usual formula Uc1 = (U V/C) x (1.73 m2/BSA) where U is the concentration of cephanone in the urine, V the timed urine volume, and C the antibiotic concentration in the serum.
RESULTS
With an intravenous infusion of approximately 250 mg (3.5 mg/kg) of cephanone, an average serum concentration of 31.9,ug/ml was present at the end of the 1st h. During the 3rd h, with a sustaining dose of approximately 100 mg/h (1.5 mg per kg per h), a steady state with an average serum level of 31.2 ug/ml was attained for the four volunteers (Fig. 1) . After an intramuscular injection of approximately 500 mg (7 mg/kg), peak serum concentrations occurred between 0.75 and 1.5 h and averaged 36.0 sg/ml. At 6 and 8 h later, the average serum concentrations were 11.2 and 6.6 jig/ml, respectively (Fig. 2) . Thus, similar serum concentrations were obtained with a single 250-mg dose of cephanone administered intravenously over 1 h and with 500 mg injected intramuscularly.
Urinary recovery of cephanone was similar after intravenous and intramuscular injections. About 55% of the dose administered was excreted in the 1st 4 h, 80% in 8 h, and 92% in 24 h. Antibiotic concentrations of over 900 ,ug/ml were present in the urine collection from 0 to 4 h, 200 ug/ml from 4 to 8 h, and at least 20 yg/ml from 8 to 24 h.
The serum half-life of cephanone, measured after the intravenous infusion had been stopped, was 2.40 h. A similar half-life of 2.63 h was calculated for the interval between 3 and 8 h after intramuscular injection. The exponential decline of the serum levels was confirmed by obtaining coefficients of correlation with a straight line of >0.98 for each of the regression lines when they were plotted on a semilogarithmic scale.
The apparent volume of distribution calculated at the steady state, during the 3rd h of the intravenous infusion, was 13.6 liters, or 16.6% of the total body weight. The total or serum clearance, measured at the same time, was 56.3 ml per min per 1.73 m2. The renal clearance of cephanone was 46.6 ml per min per 1.73 m2. Creatinine clearances were determined on the same day over 24 h and averaged 121.7 i 6.9 ml per min per 1.73 m2 (standard error of the mean). The ratio of the renal clearance of cephanone to the creatinine clearance was 0.40 ( 0.02), not significantly different from the ratio of the total or serum clearance of cephanone to the creatinine clearance, namely 0.47 (±0.05). DISCUSSION Remarkably high serum concentrations of cephanone as compared with cephalothin and cephaloridine were obtained in the present study (Table 1) . Previously, in our laboratory (7, 10), steady-state serum concentrations of 17.4 and 24.7 ;ig/ml were obtained with 500 and 250 mg of cephalothin and cephaloridine per h, respectively, as compared with a level of 31.1 Ag/ml with only 100 mg/h in the present study.
Intramuscularly, single 0.5-g injections of cephalothin gave peak blood levels about 0.25 (1, 6) , and cephaloridine about 0.50 (1, 5) , of those obtained with cephanone. In addition to its higher peak blood levels, the serum concentration of cephanone declined more slowly, giving a half-life of about 2.5 h as compared with 1.1 for cephaloridine and 0.5 for cephalothin (7 (11) . The small apparent volume of distribution of cephanone (13.6 liters) is directly related to its high serum protein binding (88%), and this factor also is partly responsible for the high blood levels and long half-life.
These pharmacological properties of cephanone are similar to those of cefazolin, which has a closely related chemical structure, with a tetrazol-1-yl rather than a sydnone group in the side chain. Peak blood levels were found to be slightly higher with cefazolin, 42 versus 36 VOL. 4, 1973 on October 14, 2017 by guest http://aac.asm.org/ ,ug/ml with 0.5 g intramuscularly, whereas the serum half-life was longer with cephanone (2.5 versus 1.8 h). These differences appear to be due to a lower renal clearance (47 versus 64 ml per min per 1.73 m2) and a slightly larger volume of distribution (13.6 versus 11.0 liters) for cephanone (C. Regamey, R. C. Gordon, and W. M. M. Kirby, 1973 , Arch. Intern. Med., in press).
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